Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Howard

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous LeukemiaMaria Queralt Salas, Shiyi Chen, Wilson Lam, et al.
Leukemia & Lymphoma|August 26, 2021
Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infectionsMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Bone Marrow Transplantation|August 18, 2020
Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategiesShruti Prem, Mats Remberger, Maria Queralt Salas, et al.
Hematology/Oncology and Stem Cell Therapy|October 13, 2020
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, et al.
European Journal of Haematology|October 13, 2020
Prolactin, a potential biomarker for chronic GVHD activityMaria Queralt Salas, Shereen Ezzat, Wilson Lam, et al.
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
Blood Cell Therapy|January 30, 2023
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving <i>in vivo</i> T-cell Depletion Transplants and Long-Term ComplicationsMaria Queralt Salas, Eshetu G Atenafu, Wilson Lam, et al.
European Journal of Haematology|August 27, 2019
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemiaMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
Bone Marrow Transplantation|June 10, 2021
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantationRam Vasudevan Nampoothiri, Lina Ho, Cassandra McEwan, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous LeukemiaMaria Queralt Salas, Shiyi Chen, Wilson Lam, et al.
Leukemia & Lymphoma|August 26, 2021
Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infectionsMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Bone Marrow Transplantation|August 18, 2020
Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategiesShruti Prem, Mats Remberger, Maria Queralt Salas, et al.
Hematology/Oncology and Stem Cell Therapy|October 13, 2020
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, et al.
European Journal of Haematology|October 13, 2020
Prolactin, a potential biomarker for chronic GVHD activityMaria Queralt Salas, Shereen Ezzat, Wilson Lam, et al.
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
Blood Cell Therapy|January 30, 2023
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving <i>in vivo</i> T-cell Depletion Transplants and Long-Term ComplicationsMaria Queralt Salas, Eshetu G Atenafu, Wilson Lam, et al.
European Journal of Haematology|August 27, 2019
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemiaMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
Bone Marrow Transplantation|June 10, 2021
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantationRam Vasudevan Nampoothiri, Lina Ho, Cassandra McEwan, et al.
Pageof 7